Does RIVASTIGMINE Cause Neoplasm malignant? 52 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 52 reports of Neoplasm malignant have been filed in association with RIVASTIGMINE (Exelon). This represents 0.6% of all adverse event reports for RIVASTIGMINE.
52
Reports of Neoplasm malignant with RIVASTIGMINE
0.6%
of all RIVASTIGMINE reports
26
Deaths
17
Hospitalizations
How Dangerous Is Neoplasm malignant From RIVASTIGMINE?
Of the 52 reports, 26 (50.0%) resulted in death, 17 (32.7%) required hospitalization, and 3 (5.8%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIVASTIGMINE. However, 52 reports have been filed with the FAERS database.
What Other Side Effects Does RIVASTIGMINE Cause?
Death (1,229)
Fall (587)
Malaise (514)
Drug ineffective (510)
Product adhesion issue (478)
Vomiting (432)
Dementia alzheimer's type (428)
Memory impairment (385)
Nausea (383)
Pneumonia (378)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which RIVASTIGMINE Alternatives Have Lower Neoplasm malignant Risk?
RIVASTIGMINE vs RIVOTRIL
RIVASTIGMINE vs RIZATRIPTAN
RIVASTIGMINE vs ROACTEMRA
RIVASTIGMINE vs ROCURONIUM
RIVASTIGMINE vs ROFECOXIB